Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)

BACKGROUND: Pegylated interferon alfa-2a (PEG-IFN-α-2a) is a potent immunomodulating agent capable of inducing high rate of hematologic and even complete molecular remission in patients with essential thrombocythemia (ET) and polycythemia vera (PV). We recently reported results of a phase 2 trial of...

Descripción completa

Detalles Bibliográficos
Autores principales: Masarova, Lucia, Yin, C. Cameron, Cortes, Jorge E., Konopleva, Marina, Borthakur, Gautam, Newberry, Kate J., Kantarjian, Hagop M., Bueso-Ramos, Carlos E., Verstovsek, Srdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679503/
https://www.ncbi.nlm.nih.gov/pubmed/29152412
http://dx.doi.org/10.1186/s40164-017-0090-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679503/
https://www.ncbi.nlm.nih.gov/pubmed/29152412
http://dx.doi.org/10.1186/s40164-017-0090-5

Ejemplares similares